Search results
Protecting therapy patients from exploitation
Politico· 10 hours agoSTUDY THIS — The implications of the public’s preexisting condition — amnesia. — US race-neutral lung assessments to have profound effects, study finds. — Moderna wins patent ...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 6 days agoThese include innovative immuno-oncology combinations, including Keytruda with TIGIT, LAG3 and...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 5 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 7 days agoWhy does Sanofi want the Novavax COVID vaccine? The Novavax COVID-19 vaccine, which is called...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 4 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Fifth Annual RTVE Showcase Puts Emphasis on International Co-Production
Variety via Yahoo News· 6 days agoSpanish public broadcaster RTVE held its fifth annual RTVE Showcase late last week in Madrid. Eight...
OpenAI’s marketing head shares the one big mistake CMOs are making with AI
Fortune via AOL· 6 days agoThere also still isn’t enough storytelling about those durable use cases that you can build with AI...
Blocking a Fair WHO Pandemic Accord Endangers Humanity
Foreign Policy Magazine· 14 hours agoIn Liu Cixin’s science fiction novel The Dark Forest—part of the popular Three-Body Problem series...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 1 day agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 5 days agoRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were...
